NANOVIRICIDES, INC. Deferred Tax Assets, Operating Loss Carryforwards
NANOVIRICIDES, INC. (NNVC) had Deferred Tax Assets, Operating Loss Carryforwards of $31.12 million as of 2025-06-30, per its 10-K filed 2025-09-29.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2025-09-29
- 2025-06-30: Deferred Tax Assets, Operating Loss Carryforwards $31.12M.
- 2024-06-30: Deferred Tax Assets, Operating Loss Carryforwards $29.35M.
- 2023-06-30: Deferred Tax Assets, Operating Loss Carryforwards $27.96M.
- 2022-06-30: Deferred Tax Assets, Operating Loss Carryforwards $27.13M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-06-30 | $31.12M 10-K · filed 2025-09-29 | |
| 2024-06-30 | $29.35M 10-K · filed 2025-09-29 | |
| 2023-06-30 | $27.96M 10-K · filed 2024-09-27 | |
| 2022-06-30 | $27.13M 10-K · filed 2023-10-13 | |
| 2021-06-30 | $26.68M 10-K · filed 2022-10-13 | |
| 2020-06-30 | $24.30M 10-K · filed 2021-10-12 | |
| 2019-06-30 | $22.19M 10-K · filed 2020-10-13 | |
| 2018-06-30 | $24.84M 10-K · filed 2019-08-23 | |
| 2017-06-30 | $23.84M 10-K · filed 2018-10-12 | |
| 2016-06-30 | $20.78M 10-K · filed 2017-09-28 | |
| 2015-06-30 | $16.39M 10-K · filed 2016-09-16 | |
| 2014-06-30 | $13.41M 10-K · filed 2015-09-14 | $11.10M 10-K · filed 2014-09-30 |
| 2013-06-30 | $6.85M 10-K · filed 2015-02-23 | |
| 2012-06-30 | $4.28M 10-K · filed 2015-02-23 | |
| 2011-06-30 | $3.66M 10-K/A · filed 2013-10-08 | $4.28M 10-K/A · filed 2012-10-26 |
| 2010-06-30 | $3.66M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |